SATURDAY, MARCH 28, 2015

SATURDAY, MARCH 28, 2015
13:00 - 14:30
Hall M1
Educational: Academia Educational Course: Part 1
Problem solving in psychopharmacotherapy using pharmacokinetic and pharmacogenetic tests
Pierre Baumann (Switzerland)
Christoph Hiemke (Germany)
Eveline Jaquenoud Sirot (Switzerland)
13:00 - 14:30
Hall M2
Educational:
Academia Educational Course: Part 1
Neurocognitive and social cognition training in schizophrenia
Gabriele Sachs (Austria)
Armida Mucci (Italy)
13:00 - 14:30
Hall N1
Educational: Academia Educational Course: Part 1
Applied phenomenological psychopathology
Giovanni Stanghellini (Italy)
13:00 - 14:30
Hall N2
Educational: Academia Educational Course:
Coping with adversity: CBT in adverse life circumstances: Part 1
Stirling Moorey (United Kingdom)
13:00 - 14:30
Hall M3
Educational: Academia Educational Course:
Internet-based CBT in psychiatry: Part 1
Nils Lindefors (Sweden)
Viktor Kaldo (Sweden)
13:00 - 14:30
Hall N3
Educational:
Academia Educational Course: Part 1
How to manage delirium in the general hospital
Albert Diefenbacher (Germany)
Antonio Barbosa (Portugal)
Dan Georgescu (Switzerland)
15:00 - 16:30
Hall M1
Educational: Academia Educational Course: Part 2
Problem solving in psychopharmacotherapy using pharmacokinetic and pharmacogenetic tests
Pierre Baumann (Switzerland)
Christoph Hiemke (Germany)
Eveline Jaquenoud Sirot (Switzerland)
15:00 - 16:30
Educational:
1|Page
Hall M2
Academia Educational Course: Part 2
Neurocognitive and social cognition training in schizophrenia
Gabriele Sachs (Austria)
Armida Mucci (Italy)
15:00 - 16:30
Hall N1
Educational: Academia Educational Course: Part 2
Applied phenomenological psychopathology
Giovanni Stanghellini (Italy)
15:00 - 16:30
Hall N2
Educational: Academia Educational Course: Part 2
Coping with adversity: CBT in adverse life circumstances
Stirling Moorey (United Kingdom)
15:00 - 16:30
Hall M3
Educational: Academia Educational Course: Part 2
Internet-based CBT in psychiatry
Nils Lindefors (Sweden)
Viktor Kaldo (Sweden)
15:00 - 16:30
Hall N3
Educational:
Academia Educational Course: Part 2
How to manage delirium in the general hospital
Albert Diefenbacher (Germany)
Antonio Barbosa (Portugal)
Dan Georgescu (Switzerland)
16:45 - 18:15
Hall M1
Satellite Symposium: Satellite Symposium 1
18:30 - 21:00
Hall A
Opening Ceremony followed by a Welcome Reception
2|Page
Sunday, March 29, 2015
08:00 - 09:30
Hall A
Research:
Symposium: The tele-therapy town - what's happening to the neighbourhood?
Chairpersons:
Jan Wise (United Kingdom)
Davor Mucic (Denmark)
 The development and evaluation of an online computer-based cognitive-behavior therapy for insomnia for Alcohol
Dependent patients
O. Zhabenko, N. Zhabenko (Ukraine)
 iPad Assisted Treatment Of Patients With Schizophrenia
A.G. Viuff (Denmark)
 Use of the internet amongst patients - a pan-European perspective
Sobieraj (Poland)
 The Shadow of The Electronic World on Patients & Healthcare Systems - A Global Perspective
J. Wise (United Kingdom)
08:00 - 09:30
Hall B
Core Programme: Research:
New insights in mental disorders and metabolism
Chairpersons:
Cyril Höschl (Czech Republic)
Marc De Hert (Belgium)
 How the brain regulates food intake
Giles Yeo (United Kingdom)
 Bipolar disorders and Diabetes
Tomas Hajek (Canada)
 Anti-psychotics and metabolism
Marc De Hert (Belgium)
 Heal Initiative - Prevention
D. Shiers (United Kingdom)
08:00 - 09:30
Hall C
Research: Symposium:
The mad axman: the relationship between psychosis and violence
Chairpersons:
Birgit Völlm (United Kingdom)
Silvana Galderisi (Italy)
 Schizophrenia and violence: An overview of research on associations, risk factors, and trends over time
S. Fazel (United Kingdom)
 Werewolf in Kakania. Moosbrugger: an analysis of his subjectivity
G. Stanghellini (Germany)
 Politicians, murder and schizophrenia: A case example
J. Beezhold (United Kingdom)
 Media Reaction to High Profile Cases and The Impact on Professionals, Public Policy and Services – The Never Ending
Paradox
T. Bergman-Levy (Israel)
3|Page
08:00 - 09:30
Hall M
Research:
Symposium: Serotonin: studies on reward, emotion, social cognition, and relevance to mood and anxiety disorders
Chairpersons:
Franz Vollenweider (Switzerland)
Rupert Lanzenberger (Austria)
 Role of serotonin in punishment and reward: New vistas
T.W. Robbins (United Kingdom)
 The effect of serotonin receptor manipulation on brain networks and its impact on emotion regulation
R. Krähenmann (Switzerland)
 The effect of 5-HT2A/1A agonist treatment on social cognition, empathy, and social decision-making
K.H. Preller, T. Pokorny, R. Krähenmann, I. Dziobek, P. Stämpfli, F.X. Vollenweider (Switzerland)
 Serotonergic neurotransmission and depression
Rupert Lanzenberger (Austria)
08:00 - 09:30
Hall N1
Research:
Symposium: Sub-threshold psychotic experiences in the general population
Chairpersons:
Silvana Galderisi (Italy)
Wolfgang Gaebel (Germany)
 Subclinical psychotic experiences: relevance, characteristics and the role of environmental factors
Ruud Van Winkel (Netherlands)
 Psychotic experiences in the general population
Wulf Roessler (Switzerland)
 Route to psychosis: what differentiates individuals with psychotic experiences with and without a ‘need for care’?
Mike Jackson (United Kingdom)
 AFFECTIVE COMORBIDITIES IN PEOPLE AT HIGH RISK FOR PSYCHOSIS
P. Fusar-Poli (United Kingdom)
08:00 - 09:30
Hall N2
Clinical:
Symposium: An update on the interface of dementia, physical health and its relevance for diagnosis and therapy
Chairpersons:
Reinhard Heun (United Kingdom)
Florian Riese (Switzerland)
 Co-morbidity and mortality in Alzheimer's disease
D. Schoepf, R. Heun (Germany)
 The relevance and diagnostic and therapeutic implications of early markers of dementia and new types of diagnostic criteria
Lucrezia Hausner (Germany)
 PET-imaging of cerebral glucose metabolism and of cerebral beta-amyloid-deposition and its value for the understanding,
early detection and differential diagnosis of Alzheimer's disease
Gietl (Switzerland)
 An update on current treatment strategies for behavioural and psychological symptoms of dementia
F. Riese (Switzerland)
08:00 - 09:30
Hall N3
Educational:
Academia Educational Course: Part 1
How to support families of patients with severe mental disorders
Andrea Fiorillo (Italy)
Umberto Volpe (Italy)
4|Page
08:00 - 09:30
Hall L1
Educational:
Symposium: Phenomenology of dysphoria
Chairpersons:
Giovanni Stanghellini (Italy)
Massimiliano Aragona (Italy)
 Dysphoria: ancient and contemporary concepts
M. Musalek (Austria)
 Dysphoria: A desperate vitality
G. Stanghellini (Italy)
 Moody Minds: Dysphoria and Schizophrenia Spectrum Psychopathology
Raballo (Italy)
 Dysphoria in mania and in depression
Otto Doerr-Zegers (Chile)
08:00 - 09:30
Hall L8
Free Communications / e-Poster Oral 1
08:00 - 09:30
ECP Hall M3
Free Communications / e-Poster Oral 2
10:00 - 11:30
Hall A
Debate:Clinical:
CBT - Is it sold-out?
Chairperson
Marianne Kastrup (Denmark)
 CBT - Is it sold-out? PRO
Peter McKenna (United Kingdom)
 CBT - Is it sold-out? CON
David Kingdon (United Kingdom)
10:00-11:30
Hall B
European:
Symposium: Quality assurance for mental health services - a European challenge
Chairpersons
Wolfgang Gaebel (Germany)
Dinesh Bhugra (United Kingdom)
 The EPA Guidance Project
W. Gaebel (Germany)
 Quality Assurance for mental health services - the UK perspective
D. Bhugra (United Kingdom)
 Assuring quality of mental health services in Italy
Mirella Ruggeri (Italy)
 Quality of European mental health services - the special situation in Eastern Europe
M. Muijen (Denmark)
5|Page
10:00 - 11:30
Hall C
Research:
Infection, immunity and mental disorder
Chairpersons:
Jiri Horacek (Czech Republic)
Philip Gorwood (France)
 Role of Toxoplasma infection in psychiatric diseases
TBA
 Title of presentation to be advised
Norbert Müller (Germany)
 Title of presentation to be advised
Jiri Horacek (Czech Republic)
 Practical Issues - anti inflammatory treatment
TBA
10:00 - 11:30
Hall M1
Research:
Symposium: New views on serotonin in brain function and psychiatric disorders
Chairpersons:
Igor Branchi (Italy)
Martin Walter (Germany)
 A brain imaging perspective on personality and environment interaction with serontonergic and glutamatergic genetic
variability
M. Walter (Germany)
 5-HTTLPR-by-stress interaction and related rodent models: two decades of progress in cognitive and behavioral
neuroscience
Klaus Peter Lesch (Germany)
 5HT2A receptors – a new target for depression?
D. Nutt (United Kingdom)
 Beneficial and adverse consequences of increased brain plasticity: the interplay among serotonin, susceptibility to the
environment and depression
Branchi (Italy)
10:00 - 11:30
Hall N1
Educational:
Symposium: Excellence of ethics and ethics of excellence
Chairpersons:
Andreas Heinz (Germany)
Olivier Andlauer (France)
 Challenges, Needs and Unmet Needs - An EPA overview of European Codes of Ethics
W. Rutz (Sweden)
 Ethical Issues of Using Information Technologies in Psychiatry: An Early Career Psychiatrists Perspective.
O. Andlauer, G. Lydall, A. Nawka, S. Guloksuz (France)
 Interactions of European Early Career Psychiatrists with the Pharmaceutical Industry: Status Quo and Directions for the
Future
F. Riese (Switzerland)
 Conflicts of Interest Setting its Limits
N. Sartorius (Switzerland)
6|Page
10:00 - 11:30
Hall N2
Educational:
WHO - World Suicide Report
Chairpersons:
Danuta Wasserman (Sweden)
Shekhar Saxena (Switzerland)
 Stakeholders
Shekhar Saxena (Switzerland)
 Epidemiology
Alexandra Fleishmann (Switzerland)
 Evidence Based Methods
Danuta Wasserman (Sweden)
 Future Reseach
Vladimir Carli (Sweden)
10:00 - 11:30
Hall N3
Educational:
Academia Educational Course: Part 2
How to support families of patients with severe mental disorders
Andrea Fiorillo (Italy)
Umberto Volpe (Italy)
10:00 - 11:30
Hall L1
Free Communications / e-Poster Oral 3
10:00 - 11:30
Hall L8
Free Communications / e-Poster Oral 4
10:00 - 11:30
ECP Hall M3
Clinical / Therapeutic Track:
Conversations with Guy Goodwin: Is it Time to Change the Current Nomenclature of Psychotropic Drugs?
Chairpersons:
Martina Rojnic Kuzman (Croatia)
Gregory Lydall (United Kingdom)
 Is it Time to Change the Current Nomenclature of Psychotropic Drugs?
Guy Goodwin (United Kingdom)
11:45 - 12:30
Hall A
Plenary Lecture: Educational:
Excellence in training - What makes a good psychiatrist?
Chairperson:
Danuta Wasserman (Sweden)
 Excellence in training - What makes a good psychiatrist?
D. Bhugra (United Kingdom)
13:15 - 14:45
Hall A, B and C
Satellite Symposium: Satellite Symposium 2, 3 and 4
7|Page
15:00 - 15:45
Hall A
State of the Art: Clinical:
Designer Drugs and Legal Highs
Chairperson:
Geert Dom (Belgium)
 Designer Drugs and Legal Highs
David Nutt (United Kingdom)
15:45 - 16:30
Hall A
State of the Art: Clinical:
Sexual Disfunctions: What can be done?
Chairperson:
Zvi Zemishlany (Israel)
 Sexual Disfunctions: What can be done?
Marcel Waldinger (Netherlands)
15:00 - 16:30
Hall B
Research:
Symposium: Negative symptoms - From psychopathology to pathophysiology
Chairpersons:
Stefan Kaiser (Switzerland)
Ann Faerden (Norway)
 Assessment of negative symptoms
S. Dollfus, C. Mach, R. Morello (France)
 The impact of negative symptoms on real life functioning of people with schizophrenia
S. Galderisi (Italy)
 Neuroimaging correlates of negative symptoms
Florian Schlagenhauf (Germany)
 Neural correlates of rTMS treatment of negative symptoms
Aleman, J. Dlabac-de Lange, E. Liemburg, H. Knegtering (Netherlands)
15:00 - 16:30
Hall C
Clinical:
Symposium: Neurodevelopmental disorders across lifespan: an overview
Chairpersons:
Josep Ramos-Quiroga (Spain)
Esther Sobanski (Germany)
 Understanding comorbidity of neurodevelopmental disorders
Philip Asherson (United Kingdom)
 ADHD: a neurodevelopmental disorder
J.J.S. Kooij (Netherlands)
 Autism: a neurodevelopmental disorder
Van Elst Van Elst (Germany)
 Schizophrenia as a neurodevelopmental disorder
Rene Kahn (Netherlands)
8|Page
15:00 - 16:30
Hall M
Clinical:
Symposium: Psychopharmacotherapy at the interface of psychiatric and medical diseases
Chairpersons:
Ronald Burian (Germany)
Istvan Bitter (Hungary)
 Psychopharmacotherapy in cardiovascular diseases
S. Kasper (Austria)
 Psychopharmacotherapy in neurologic and epileptologic diseases
Ulrik Malt (Norway)
 Psychopharmacotherapy in endocrine and metabolic diseases
G. Laux (Germany)
 Psychopharmacotherapy in gastrointestinal and liver diseases
D. Telles-Correia, A. Barbosa (Portugal)
15:00 - 16:30
Hall N1
European:
Workshop: Geriatric psychiatry and primary care mental health: an EPA and WONCA joint workshop
Chairpersons:
Carlos Augusto De Mendonça Lima (Portugal)
Henk Parmentier (United Kingdom)
 Ambulatory care for dementia in Switzerland: results of a nationwide survey
G. Stoppe, M. Trombini, L. Maeck (Switzerland)
 Primary Care for Older Persons with Mental Disorders at UK
Henk Parmentier (United Kingdom)
 Carer's Needs Assessment for Dementia
J. Wancata, A. Unger, Z. Litvan (Austria)
 Primary Care Mental Health for Older Persons and the WHO Mental Health Plan 2013-2020
C.A. De Mendonça Lima (Portugal)
15:00 - 16:30
Hall N2
Educational:
Academia Educational Course: Part 1
Risk assessment and risk management in general psychiatry
Kris Goethals (Belgium)
15:00 - 16:30
Hall N3
Educational: Academia Educational Course: Part 1
The pharmacological management of mood disorders and psychosis in pregnancy and lactation
Angelika Wieck (United Kingdom)
Maria Muzik (USA)
15:00 - 16:30
Hall L1
Free Communications / e-Poster Oral 5
15:00 - 16:30
Hall L8
Free Communications / e-Poster Oral 6
9|Page
15:00 - 16:30
ECP Hall M3
Clinical / Therapeutic Track:
Court debates: Cyber Addictions are Real Addictions
Chairpersons:
Olivier Andlauer (France)
Judge:
Sue Bailey (United Kingdom)
 Opponent: Philip Gorwood (France)
 Defendant: Sophia Achab (Switzerland)
17:00 - 18:30
Hall A
European:
Horizons 2020 - A new approach to European research funding and its implications for psychiatry research: A joint symposium
with the European Brain Council (EBC)
Chairpersons:
David Nutt (United Kingdom)
Patrice Boyer (France)
 Which innovative programmes should be designed in psychiatry?
David Nutt (United Kingdom)
 Practical aspects in answering Horizon 2020 calls
Patrice Boyer (France)
17:00 - 18:30
Hall B
Research:
Symposium: The aetiopathogenesis of schizophrenia - genes, the brain and the environment
Chairpersons:
Wolfgang Gaebel (Germany)
Sophia Frangou (USA)
 Integrating neurobiology, neurogenetics and psychosocial research - a novel systems approach in schizophrenia research
Sophia Frangou (USA)
 From genes to phenotypes - how to bridge the gap
Andreas Meyer-Lindenberg (Germany)
 Developing a neuropsychological model of delusions
Werner Strik (Switzerland)
 Genetics of schizophrenia - where to go next?
 M. Owen (United Kingdom)
17:00 - 18:30
Hall C
Clinical:
Symposium: Off label use of psychopharmacologic/CNS drugs: Pro's and con's
Chairpersons:
Istvan Bitter (Hungary)
Julio Bobes (Spain)
 Off label use of antidepressants: pro's and con's
H. Möller (Germany)
 Off label use of antipsychotics: pro's and con's
Istvan Bitter (Hungary)
 Off label use of other CNS drugs (e.g.psychostimulants, anticonvulsants, lithium): Pro's and con's
P. Baumann (Switzerland)
 Off label use of drugs with special focus on CNS: Views from the industry
R. Conley (USA)
10 | P a g e
17:00 - 18:30
Hall M
Research:
Workshop: Electroconvulsive therapy and the ageing brain
Chairpersons:
Mathieu Vandenbulcke (Belgium)
Pascal Sienaert (Belgium)
 Age as a risk factor for predicting cognitive deficits following ECT
D. McLoughlin, D. McCloughlin (Ireland)
 The structure of the geriatric depressed brain and response to ECT
M.L. Stek, M.L. Oudega, A.M. Dols, H.C. Comijs, P. Eikelenboom, E. Exel van (Netherlands)
 The effect of ECT on brain grey matter, insights from longitudinal MRI
F. Bouckaert, F.L. Dewinter, L. Emsell, A. Dols, D. Rhebergen, M. Wampers, M. Stek, P. Sienaert, M. Vandenbulcke (Belgium)
 How do age-related white matter changes such as MRI hyperintensities and amyloid deposition relate to ECT outcome in
late life depression?
L. Emsell, F. Bouckaert, F.L. De Winter, J. Obbels, A. Dols, M. Stek, P. Sienaert, S. Sunaert, M. Vandenbulcke (Belgium)
17:00 - 18:30
Hall N1
Clinical:
Workshop: Outcome measurement in routine clinical practice
Chairpersons:
Victor Buwalda (Netherlands)
Julian Neil Beezhold (United Kingdom)
 Introduction Principles of Donabedian and Validation of the Honos and Oq-45 in the Netherlands
V.J.A. Buwalda (Netherlands)
 Influence of feedback and attitude of patient and clinician toward outcome measurement.
J. Beezhold (United Kingdom)
 Experience and Challenges of Implementing Outcome-based Measures in Routine Psychiatric Practice
Malik, A.M.I.T. Malik (United Kingdom)
 New It Possibilities to Enhance the Quality of the Clinical Care Process
C.J. Sleeboom - van Raaij (Netherlands)
17:00 - 18:30
Hall N2
Educational:
Academia Educational Course: Part 2
Risk assessment and risk management in general psychiatry
Kris Goethals (Belgium)
17:00 - 18:30
Hall N3
Educational: Academia Educational Course: Part 2
The pharmacological management of mood disorders and psychosis in pregnancy and lactation
Angelika Wieck (United Kingdom)
Maria Muzik (USA)
17:00 - 18:30
Hall L1
Free Communications / e-Poster Oral 7
17:00 - 18:30
Hall L8
Free Communications / e-Poster Oral 8
17:00 - 18:30
Research Track:
11 | P a g e
ECP Hall M3
mPIVAS Symposium: Schizophrenia - Combination of Treatment Approaches
Chairpersons:
Katja Koelkebeck (Germany)
Maja Pantovic (Serbia)
 The Art of Prescribing Antipsychotics in Schizophrenia
Stefan Leucht (Germany)
 Psychotherapy in Schizophrenia
Julian Leff (United Kingdom)
 Psychoeducation in Schizophrenia
Rebekka Lencer (Germany)
 Results from the mPIVAS Project
Martina Rojnic Kuzman (Croatia)
 Results from the mPIVAS Project
Olivier Andlauer (France)
18:45
TBC
EPA General Assembly and Membership Round table
This event is reserved for EPA Members.
12 | P a g e
Monday, March 30, 2015
08:00 - 09:30
Hall B
Research: Symposium:
The use of computational techniques to automatically classify diagnosis and outcome of psychiatric disorders using neuroimaging
data
Chairpersons:
Sophia Frangou (USA)
Michael Musalek (Austria)
 Computational approaches to the examination of the functional architecture of the human brain
G. Langs (USA)
 Using multimodal MRI data to classify patients with first episode psychosis
P. Brambilla, P. Denis, C. Umberto, P. Cinzia, B. Marcella, M. Veronica, R. Gianluca, L. Antonio, T. Sarah, D. Katia, M. Vittorio,
R. Mirella (Italy)
 USING SUPPORT VECTOR MACHINE TO PREDICT RESPONSE TO TREATMENT AND ILLNESS COURSE: THE IMPACT OF
SCANNER AND MULTIPLE CLINICAL OUTCOMES
P. Dazzan (United Kingdom)
 Early Recognition and Disease Prediction in the At-Risk Mental States for Psychosis Using Neurocognitive Pattern
Classification
Eva Meisenzhal (Germany)
08:00 - 09:30
Hall C
Clinical:
Treatment Resistant Depression
Chairpersons:
Siegfried Kasper (Austria)
Julian Neil Beezhold (United Kingdom)
 Prediction of the therapeutic outcome
M. Bares, T. Novak, C. Höschl (Czech Republic)
 Acquired Resistance in unipolar depression
Philip Gorwood (France)
 Treatment resistant bipolar depression
Eduard Vieta (Spain)
 European program for treatment resistant depression
S. Kasper (Austria)
08:00 - 09:30
Hall M
Research:
Symposium: Suicide and the brain: a synthesis
Chairpersons:
Fabrice Jollant (Canada)
Kees Van Heeringen (Belgium)
 Neurocognitive impairments in suicide attempters and their relatives
F. Jollant (Canada)
 Is there a neuroanatomical basis for the vulnerability to suicide?
S. Bijttebier, S. Desmyter, M. Vervaet, C. Baeken (Belgium)
 CSF Biomarkers of suicidal behavior
J. Jokinen (Sweden)
 Epigenetic changes in the suicidal brain
Gustavo Turecki (Canada)
13 | P a g e
08:00 - 09:30
Hall N1
Research:
Symposium: Long-term brain effects of antipsychotics - balancing harm and benefit
Chairpersons:
Andreas Heinz (Germany)
Lex Wunderink (Netherlands)
 Brain abnormalities and outcome in people with schizophrenia – recent findings
Heinz, C. Hägele, S. Weinmann, V. Aderhold (Germany)
 Brain atrophy and antipsychotic medication – a systematic review
S. Weinmann, V. Aderhold, C. Haegele, A. Heinz (Germany)
 The effect of antipsychotic dose-reduction on cognition
H. Takeuchi (Japan)
 Long term recovery rates in schizophrenia after early antipsychotic dose reduction
L. Wunderink, R. Nieboer, F. Nienhuis, S. Sytema, D. Wiersma (Netherlands)
08:00-09:30
Hall N2
Research: Symposium:
Can psychiatric disorders be predicted and prevented?
Chairperson:
Joachim Klosterkötter (Germany)
Danuta Wasserman (Sweden)
 Suicide Prevention
Danuta Wasserman (Sweden)
 Prevention of Bipolar and Depressive Disorders: Is this an Attainable Goal?
C.U. Correll (USA)
 Prediction and Indicated Prevention of Psychoses
S. Ruhrmann, F. Schultze-Lutter, S.J. Schmidt, J. Klosterkötter (Germany)
 Prevention of Alcohol Addiction
Wim Van den Brink (Netherlands)
08:00 - 09:30
Hall N3
Educational:
Academia Educational Course: Part 1
Motivational interviewing in addiction: How can we help patients change behaviour and habits?
Lieve De Backer (Belgium)
Gerard Schipppers (Netherlands)
08:00 - 09:30
Hall L1
Educational: Academia Educational Course: Part 1
Leadership skills in psychiatry
Dinesh Bhugra (United Kingdom)
14 | P a g e
08:00 - 09:30
Hall L8
Research:
Workshop: Negative symptoms, cognitive impairment and social cognition in schizophrenia
Chairpersons:
Silvana Galderisi (Italy)
Wolfgang Gaebel (Germany)
 Modeling relationships between negative symptoms, neurocognition and social cognition
S. Galderisi, A. Mucci, A. Rossi, P. Rocca, A. Bertolino, P. Bucci, M. Maj (Italy)
 Differential associations of negative symptom dimensions with cognition and decision-making
S. Kaiser (Switzerland)
 Apathy in psychotic disorders: Relationship to neurocognition
Ann Faerden (Norway)
 Negative symptoms and neural correlates of affective ambiguity
André Aleman (Netherlands)
08:00 - 09:30
Hall L4
Clinical: Workshop:
Cognitive behavioral therapy with schema therapy in the treatment of personality disorders
Chairpersons:
Jan Prasko (Czech Republic)
Vyskocilova Jana (Czech Republic)
 Integration of schema therapy and cognitive behavioral therapy in the treatment of perosnality disorders
M. Slepecky, A. Kotianova, J. Vyskocilova, J. Prasko (Slovakia)
 Transference and countertransference in CBT and schematherapy of personality disorders
J. Vyskocilova, J. Prasko, M. Slepecky, A. Kotianova (Czech Republic)
 Experiential techniques in the CBT treatment of personality disorders
Kotianova, M. Slepecky, J. Vyskocilova, J. Prasko (Slovakia)
 Emotional processing using role playing and therapeutic letters in the treatment of personality disorders
J. Prasko, J. Vyskocilova, M. Slepecky, A. Kotianova (Czech Republic)
08:00 - 09:30
ECP Hall M3
European Track:
Symposia: Psychotherapy Update
Chairpersons:
Nikolina Jovanovic (Croatia)
Slavica Nikolic Lalic (Serbia)
 Reviewing evidence: Online vs face-to-face psychotherapy
Gerhard Andersson (Sweden)
 How to Choose the Best Psychotherapy Training for Yourself?
Marc Hermans (Belgium)
 Is Psychotherapy Part of my Identity as a Psychiatrist? - Results from the EFPT Study
Alina Petricean-Braicu (United Kingdom)
 Psychotherapy in Practice - an Example of Applying Different Models and Theories to a Clinical Case
Ana Moscoso (Portugal)
15 | P a g e
10:00 - 11:30
Hall B
Debate: Research:
Can computers replace psychotherapists?
Chairpersons:
Danuta Wasserman (Sweden)
 Can Computers replace Psychotherapists? PRO
Martin Bohus (Germany)

Can Computers replace Psychotherapists? CON
Gerhard Andersson (Sweden)
10:00 - 11:30
Hall C
Research:
Workshop: Developing mental health research and enhancing clinical practice using health records data
Chairpersons:
Robert Stewart (United Kingdom)
Karen Ritchie (France)
 Developing electronic health records databases for mental health research
R. Stewart (United Kingdom)
 Developing research and clinical practice using health records data - a French perspective
Karen Ritchie (France)
 The use of natural language processing to transform health records information
Roberts (United Kingdom)
 Developing research and clinical practice using health records data - a Spanish perspective
J.A. Cervilla, M.D. Aguilera (Spain)
10:00 - 11:30
Hall M
Core Symposium European:
New Nomenclature for Psychotropic Drugs - ECNP Symposium hosted by EPA
Chairpersons:
Wolfgang Gaebel (Germany)
Guy Goodwin (United Kingdom)
 The need for a new nomenclature of psychotropic drugs
David Nutt (United Kingdom)
 Summary of the new nomenclature of psychotropic drugs
Guy Goodwin (United Kingdom)
 New applications to gain access to the new nomenclature of psychotropic drugs
Joseph Zohar (Israel)
16 | P a g e
10:00 - 11:30
Hall N1
Research:
Symposium: The role of neuroinflammation and infection in bipolar disorder and schizophrenia
Chairpersons:
Cyndi Shannon-Weickert (Australia)
Arjen Sutterland (Netherlands)
 Identification of Subgroups of Schizophrenia Patients With Changes in Either Immune or Growth Factor and Hormonal
Pathways.
Nico Van Beveren (Netherlands)
 Transdiagnostic exploration of the association of Toxoplasma gondii with psychiatric disorders. A systematic review and
meta analysis.
Sutterland, G. Fond, A. Kuin, M. Koeter, R. Lutter, T. Van Gool, R. Yolken, A. Szoke, M. Leboyer, L. De Haan (Netherlands)
 Interactions between immune gene variants and environmental factors in bipolar disorder
Marion Leboyer (France)
 Therapeutic trials of minocycline, ondansetron and simvastatin in schizophrenia.
J. Deakin, I.B. Chaudhry, A. Parker, G. Dunn, A. Kazmi, R. Drake, R. Ur Rahman, M. Hamirani, T. Kiran, N. Mehmood, N.
Husain (United Kingdom)
10:00 - 11:30
Hall N2
Research:
Symposium: Infidelity: is it normal or pathological?
Chairpersons:
Marcel Waldinger (Netherlands)
Zvi Zemishlany (Israel)
 Is Infidelity Biologically Determined?
R. Balon (USA)
 A new Neurobiology of Libido: A Complex Interplay between Testosterone, 5-HT and 5-HT1A receptor Functioning
M.D. Waldinger (Netherlands)
 Managing drug-induced sexual dysfunction
T. Segraves (USA)
 Are men and women socially or sexually monogamous?
Z. Zemishlany (Israel)
10:00 - 11:30
Hall N3
Educational:
Academia Educational Course: Part 2
Motivational interviewing in addiction: How can we help patients change behaviour and habits?
Lieve De Backer (Belgium)
Gerard Schipppers (Netherlands)
10:00 - 11:30
Hall L1
Educational: Academia Educational Course: Part 2
Leadership skills in psychiatry
Dinesh Bhugra (United Kingdom)
17 | P a g e
10:00 - 11:30
Hall L8
Research:
Symposium: Childhood trauma in severe mental disorders: clinical expression and mechanisms
Chairpersons:
Ingrid Melle (Norway)
Chantal Henry (France)
 Childhood trauma and the clinical expression of bipolar disorders and psychosis
B. Etain, M. Aas, F. Bellivier, I. Melle, C. Henry, S. Gard, J.P. Kahn, M. Leboyer (France)
 The Effects of Childhood Trauma On Limbic Structure and Connectivity: A Multimodal Mri Study in Healthy Subjects
J. De Souza Queiroz, B. Etain, J. Boisgontier, C. Poupon, D. Duclap, M.A. D´Albis, C. Daban, N. Handami, C. Cabon, M.
Delavest, F. Bellivier, M. Leboyer, H. Chantal, J. Houenou (France)
 Biomarkers and childhood trauma
Cattaneo, G. Plazzotta, M.A. Riva, C.M. Pariante (United Kingdom)
 Childhood trauma / gene (BDNF, 5HTTLPR) interactions in psychosis: impact on cognition
M. Aas, S. Djurovic, U.K. Haukvik, M. Tesli, L. Athanasiu, I. Agartz, O.A. Andreassen, I. Melle (Norway)
10:00 - 11:30
Hall L4
Free Communications / e-Poster Oral 9
10:00 - 11:30
ECP Hall M3
Educational Track :
Conversations with Catherine Quarini: How to Publish in Psychiatry
Chairpersons:
Florian Riese (Switzerland)
Mariana Pinto da Costa (Portugal)
 How to Publish in Psychiatry
Catherine Quarini (United Kingdom)
11:45 - 12:30
Hall B
Plenary Lecture: Research:
Precision Medicine for Psychiatry: The NIMH Research Domain Criteria (RDoC) Project
Chairpersons:
Wolfgang Gaebel (Germany)
 Precision Medicine for Psychiatry: The NIMH Research Domain Criteria (RDoC) Project
Bruce Cuthbert (USA)
13:15-14:30
Hall B, C and M
Satellite Symposium: Satellite Symposium 5, 6, 7
15:00 - 15:45
Hall B
State of the Art: Clinical:
Borderline Personality Disorders
Chairperson:
Silvana Galderisi (Italy)
 Borderline Personality Disorders
G. Liotti (Italy)
18 | P a g e
15:45 - 16:30
Hall B
State of the Art: Clinical:
Sleep disorders in psychiatric patients
Chairperson:
Tamas Kurimay (Hungary)
 Sleep disorders in psychiatric patients
Thomas Pollmächer (Germany)
15:00 - 16:30
Hall M
European:
EPA/WHO Joint Symposium Improving the Quality of Mental Health Care in Europe
Chairpersons:
Wolfgang Gaebel (Germany)
Matt Muijen (Denmark)
 Responding to challenges and taking actions
Matt Muijen (Denmark)
 The EPA Survey on Mental Health Care Quality in European Countries - Results and Implications for Action
Tamas Kurimay (Hungary)
 Improving Quality of Mental Health Care across Europe - the Perspective of GAMIAN
Pedro Montellano (Portugal)
 WHO EMHAP and EPA Guidance - Joint Actions and Implementation for better Mental Health in Europe
Wolfgang Gaebel (Germany)
15:00 - 16:30
Hall N1
Educational: Symposium:
Prevention of mental disorders in children of mentally ill parents
Chairpersons:
Hans Grabe (Germany)
Stephan Lawrie (United Kingdom)
 Mentally ill parents and their children
H. Grabe (Germany)
 Early risk prediction of schizophrenia in children and adolescents
Stephan Lawrie (United Kingdom)
 Transgenerational experiences of childhood adversities in the development of adolescent borderline personality disorder
Romuald Brunner (Germany)
 Gene-environment and timing in the trans-generational transmission of mood disorders
Gil Zalsman (Israel)
15:00 - 16:30
Hall N2
Research:
Symposium: Neuroprogression and neuroprotection in bipolar disorder
Chairpersons:
Natalie Rasgon (USA)
Roger McIntyre (Canada)
 Brain derived neurotrophic factor and biomarkers of insulin resistance in women with BD
N. Rasgon (USA)
 Bipolar Disorder: The Implications of Metabolism and Inflammation to Pathogenesis and Treatment
R. McIntyre (Canada)
 Biomarkers of Neuroprogression in Bipolar Disorder
F. Kapczinski (Brazil)
 Neuroprotection in the aftermath of a first episode of mania.
M. Berk, R. Daglas, M. Yucel, O. Dandash, S.M. Cotton (Australia)
19 | P a g e
15:00 - 16:30
Hall N3
Research:
Staging in major psychosis and mood disorders: news and views from around the world...
Chairpersons:
Marion Leboyer (France)
Philippe Conus (Switzerland)
 Staging from the Australian perspective
Seetal Dodd (Australia)
 Staging from the Brazilian perspective
Aroldo Dargel (France)
 Staging concept in first episode psychosis in Switzerland
Philippe Conus (Switzerland)
 Stages in a French cohort of bipolar disorder (FACE-BD)
Bruno Etain (France)
15:00 - 16:30
Hall N3
Educational:
Academia Educational Course: Part 1
Practical training for evaluation of suicidal risk
Vladimir Carli (Sweden)
Marco Sarchiapone (Italy)
Danuta Wasserman (Sweden)
15:00 - 16:30
Hall L1
Educational: Academia Educational Course: Part 1
Understanding psychosis: a psychopathological guide for clinical examination:
Andrea Raballo (Italy)
Peter Handest (Denmark)
Frank Larøi (Belgium)
15:00 - 16:30
Hall L8
Free Communications / e-Poster Oral 10
15:00 - 16:30
Hall L4
Free Communications / e-Poster Oral 11
15:00 - 16:30
ECP Hall M3
European Track:
Court debates: Psychiatrists are a Dying Species
Chairperson:
Alexander Nawka (Czech Republic)
Judge: Andrea Fiorillo (Italy)
 Opponent: Norman Sartorius (Switzerland)
 Defendant: Dinesh Bhugra (United Kingdom)
20 | P a g e
17:00 - 18:30
Hall B
Clinical:
Treatment Goals beyond Symptom Reduction?
Chairpersons:
Michael Musalek (Austria)
Levent Küey (Turkey)
 Treatment Goals in good clinical practice: Quality of Life
Levent Küey (Turkey)
 Treatment Goal: Functioning
Pavel Mohr (Czech Republic)
 Treatment Goal: Recovery
Heinz, L. Mahler, C. Montag, C. Müller (Germany)
 Treatment Goal: Autonom and Joyful Lifey
M. Musalek (Austria)
17:00 - 18:30
Hall C
Symposium
Joint symposia between the Asian Federation of Psychiatric Associations (AFPA) and EPA
Chairpersons:
Wolfgang Gaebel (Germany
17:00 - 18:30
Hall M
Research:
Economic crisis and its bearing upon mental health. From facts to prevention
Chairpersons:
Manuel Martin-Carrasco (Spain)
Geert Dom (Belgium)
 The financial crisis and the future of mental health in Greece
Nikos Christodoulou (United Kingdom)
 Stigma, unemployment and mental health in the context of economic hardship.
Sara Evans-Lacko (United Kingdom)
 Rethinking mental health evaluation research and prevention programs.
Kristian Wahlbeck (Finland)
 Health protection in times of economic crisis: challenges and opportunities for Europe
David McDaid (United Kingdom)
17:00 - 18:30
Hall N1
European:
Workshop: Coercion in psychiatric services in different European countries
Chairpersons:
Tilman Steinert (Germany)
Matthias Jaeger (Switzerland)
 Coercion in psychiatric services in Finland
Putkonen (Finland)
 Coercion in psychiatric services in Switzerland
M. Jaeger (Switzerland)
 Coercion in psychiatric services in the Netherlands
Eric Noorthoorn (Netherlands)
 Use of coercion in psychiatric services in Germany
T. Steinert (Germany)
17:00 - 18:30
21 | P a g e
Hall N2
European:
Symposium: Workforce migration and brain drain
Chairpersons:
Norman Sartorius (Switzerland)
Afzal Javed (Pakistan)
 Migration and mental health
D. Bhugra (United Kingdom)
 Workforce migration and brain drain in psychiatry trainees
M. Pinto da Costa (Portugal)
 Brain drain of health professionals - view from WPA
Afzal Javed (Pakistan)
 The impact of international migration - view from WHO
M. Muijen (Denmark)
10:00 - 11:30
Hall N3
Educational:
Academia Educational Course:
Practical training for evaluation of suicidal risk
Vladimir Carli (Sweden)
Marco Sarchiapone (Italy)
Danuta Wasserman (Sweden)
17:00 - 18:30
Hall L1
Educational: Academia Educational Course: Part 2
Understanding psychosis: a psychopathological guide for clinical examination
Andrea Raballo (Italy)
Peter Handest (Denmark)
Frank Larøi (Belgium)
17:00 - 18:30
Hall L8
Clinical:
Workshop: Lesbian, gay, bisexual, and transgender affirmative psychiatry: the next generation
Chairpersons:
Howard Rubin (USA)
Christopher McIntosh (Canada)
 Applying Concepts of Well-Being to the Treatment of Lesbian, Gay, Bisexual, and Transgender Patients
H. Rubin (USA)
 Psychiatric Assessment of Transgender Adults for Sex Reassignment Surgery
C. McIntosh (Canada)
 Equal Justice for All: Care of LGBT Youth in the Juvenile Justice System
J. Weiss (USA)
 Suicide and Sexual Orientation – An Overview
M. Plöderl (Australia)
22 | P a g e
17:00 - 18:30
Hall L4
Free Communications / e-Poster Oral 12
17:00 - 18:30
ECP Hall M3
Educational Track:
Training Workshop: Psychotherapy
Chairpersons:
Amit Malik (United Kingdom)
Ozge Kilic (Turkey)
 Innovations in Psychotherapy Education
Priyanthy Weerasekera (Canada)
John Manring (USA)
18:45-19:30
Halls B, C and M
Satellite Symposium: Satellite Symposium 8, 9, 10
23 | P a g e
Tuesday, March 31, 2015
08:00 - 09:30
Hall B
Educational:
Workshop: The psychiatrist as a perpetrator and victim of violence
Chairpersons:
Kris Goethals (Belgium)
Norbert Nedopil (Germany)
 About mad and bad psychiatrists
K. Goethals (Netherlands)
 Sexual misconduct by psychiatrists and psychotherapists
C. Paul (Belgium)
 Violence against doctors in Catalonia and proceedings by the Catalonia Medical Council
E.L. Gomez-Duran, V. Tort-Herrando, J. Arimany-Manso (Spain)
 Stalking and the Law – an Israeli Legal System Based Analysis
O. Asman (Israel)
08:00-09:30
Hall C
Research:
Social aesthetics in psychiatry * atmosphere in clinical settings - Joint Symposium with hosting NPA
Chairpersons:
Georg Psota (Austria)
Wolfgang Gaebel (Germany)
 Atmosphere and social aesthetics
Michael Musalek (Austria)
 Atmosphere: where the possible becomes possible
Guenda Bernegger (Switzerland)
 From anaesthetic to aesthetic: Connective aesthetics in the clinic
Helena Fox (United Kingdom)
 Cinematherapeutic interventinos: Films and atmosphere
Martin Poltrum (Austria)
08:00 - 09:30
Hall M
Research:
Symposium: Crestar: personalized medicine in schizophrenia - development of pharmacogenomics biomarkers
Chairpersons:
Dan Rujescu (Germany)
David A. Collier (United Kingdom)
 Genome wide association studies for typical antipsychotics
Dan Rujescu (Germany)
 New studies on clozapine treatment in psychosis
J.P.A.M. Bogers, D.J. Touw, J.W. Kosterink, A.J.M. Loonen (Netherlands)
 Polygenetic risk scores and metabolic side effects in clozapine treatment of schizophrenia
E. Sigurdsson, O. Ingimarsson (Iceland)
 How can pharmacogenomics biomarkers be translated into patient benefit
David A. Collier (United Kingdom)
24 | P a g e
08:00 - 09:30
Hall N1
Core Sympsoium: Clinical:
Recovery in Schizophrenia: Are we doing enough?
Chairpersons:
Silvana Galderisi (Italy)
Cécile Hanon (France)
 What is relevant for recovery
Silvana Galderisi (Italy)
 Treatment Plans
Wolfgang Fleischhacker (Austria)
 Community Psychiatry and Empowerment
Jean-Luc Roelandt (France)
 Early Treatment in schizophrenia
Istvan Bitter (Hungary)
08:00 - 09:30
Hall N2
Clinical:
Symposium: Providing psychiatric services as needed by mentally ill persons
Chairpersons:
Johannes Wancata (Austria)
Mirella Ruggeri (Italy)
 Needs of family caregivers of schizophrenia patients
F. Friedrich, J. Wancata (Austria)
 Employment and mental health
W. Kawohl (Switzerland)
 Evaluating innovative mental health care in Germany
T. Becker, A. Stierlin, R. Kilian (Germany)
 Evaluation of Community Mental Health Services
Mirella Ruggeri (Italy)
08:00 - 09:30
Hall N3
Educational:
Academia Educational Course: Part 1:1
Writing, publishing and reviewing a clinical scientific paper
Povl Munk-Jørgensen (Denmark)
C Lauber (United Kingdom)
08:00 - 09:30
Hall L1
European:
Workshop: The recent EU-funded imaging projects in psychiatry: presentation and update
Chairpersons:
Paolo Brambilla (Italy)
Sophia Frangou (USA)
 TRIMAGE - Development of a simultaneous trimodal (PET/MR/EEG) imaging tool for early diagnosis of schizophrenia and
other mental disorders
Del Guerra (Italy)
 PRONIA - Personalised Prognostic Tools for Early Psychosis Management
Nikolaos Koutsouleris (Germany)
 PSYSCAN
Philip McGuire (United Kingdom)
 IMAGEMEND - IMAging GEnetics for MENtal Disorders
Andreas Meyer-Lindenberg (Germany)
25 | P a g e
08:00 - 09:30
Hall L8
Free Communications / e-Poster Oral 13
08:00 - 09:30
Hall L4
Free Communications / e-Poster Oral 14
08:00 - 09:30
ECP Hall M3
European:
Workshop: Training in psychiatry throughout Europe
Chairpersons:
Rutger Jan Van der Gaag (Netherlands)
Marc Hermans (Belgium)
 A European Standard for Training
Andrew Brittlebank (United Kingdom)
 Need for Training in Cultural Psychiatry-Lessons for Europe
D. Bhugra (United Kingdom)
 Psychotherapy: from neglected training to neglected competency
Marc Hermans (Belgium)
 The Perspective of Trainees on the Psychiatry Training
M. Pinto da Costa (Portugal)
 Challenges of early career psychiatrists in Europe
Alexander Nawka (Czech Republic)
10:00 - 11:30
Hall B
Debate: Educational:
Is Neuroimaging over-valued in unravelling the causes of mental illness?
Chairperson:
Patrice Boyer (France)
 Is Neuroimaging over-valued in unravelling the causes of mental illness? CON
Sophia Frangou (USA)
 Is Neuroimaging over-valued in unravelling the causes of mental illness? PRO
Andreas Meyer-Lindenberg (Germany)
10:00 - 11:30
Hall C
Educational:
ICD-11
Chairpersons:
Wolfgang Gaebel (Germany)
Geoffrey M. Reed (Switzerland)
 ICD Process and Present Status
Geoffrey M. Reed (Switzerland)
 Mood Disorders in ICD-11
Mario Maj (Italy)
 Personality Disorders in ICD-11
Peter J. Tyrer (United Kingdom)
 Psychotic Disorders
Wolfgang Gaebel (Germany)
26 | P a g e
10:00 - 11:30
Hall M
Core Programme: Clinical:
ADHD - Lifecycle
Chairpersons:
Istvan Bitter (Hungary)
Josep Ramos-Quiroga (Spain)
 Biological Basis of ADHD
Philip Asherson (United Kingdom)
 Clinical Presentation of ADHD
Esther Sobanski (Germany)
 Treatment of ADHD through the Lifespan
Josep Ramos-Quiroga (Spain)
 Comorbidity of ADHD - the role of age and sex 3
Istvan Bitter (Hungary)
10:00 - 11:30
Hall N1
European:
Symposium: Which political actions for mental health need to be prioritised in Europe? Results of the EU joint action on mental
health and wellbeing situation analysis
Chairpersons:
José Caldas de Almeida (Portugal)
Kristian Wahlbeck (Finland)
 The EU policy context of the Joint Action Mental Health and Well-being
Jurgen Scheftlein (Luxembourg)
 The policy context of depression and suicide prevention in Europe. Results of the Joint Action situation analysis
G. Purebl, T. Kurimay (Hungary)
 Mental health in school setting in the context of the Mental health and Well-being Joint Action
Mass Mirandola (Italy)
 Engagement of non-health sectors in mental health promotion
Kristian Wahlbeck (Finland)
10:00 - 11:30
Hall N2
Clinical:
Symposium: Treating suicidal patients: an integrated perspective
Chairpersons:
Marco Sarchiapone (Italy)
Philippe Courtet (France)
 Psychological treatment of suicidal patients
Nestor Kapusta (Austria)
 The management of suicidal patients
Doina Cosman (Romania)
 Suicide in adolescents: What's new?
Gil Zalsman (Israel)
 Pharmacologial prevention of suicide
Z. Rihmer (Hungary)
27 | P a g e
10:00 - 11:30
Hall N3
Educational:
Academia Educational Course: Part 1:2
Writing, publishing and reviewing a clinical scientific paper:
Povl Munk-Jørgensen (Denmark)
Christoph Lauber (Switzerland)
10:00 - 11:30
Hall L1
Clinical:
Workshop: User involvement in mental health care
Chairpersons:
Michaela Amering (Austria)
Thomas Bock (Germany)
 Peer to Peer - Support in severe mental disorders: Affective Disorders, Psychosis and Personality disorder – a randomized
controlled Trial
Candelaria Mahlke (Germany)
 User Involvement in mental health care teaching
M.J. Fellinger, M. Amering (Austria)
 Family peer support in a metropolitan area
Thomas Bock (Germany)
 The importance of service-user communities. Is mainstreaming always the answer?
R. Warner (USA)
10:00 - 11:30
Hall L8
Free Communications / e-Poster Oral 15
10:00 - 11:30
Hall L4
Free Communications / e-Poster Oral 16
10:00 - 11:30
ECP Hall M3
Free Communications / e-Poster Oral 17
11:45 - 12:30
Hall B
Plenary Lecture: Research:
Opportunities and Risks of Social Media in Relation to Mental Health
Chairperson:
Patrice Boyer (France)
 Opportunities and Risks of Social Media in Relation to Mental Health
Marc Potenza (Canada)
13:15-14:45
Hall B and C
Satellite Symposium: Satellite Symposium 11, 12
28 | P a g e
15:00 - 15:45
Hall B
State of the Art: Clinical:
Dementia
Chairperson:
Sue Bailey (United Kingdom)
 Dementia
Bengt Winblad (Sweden)
15:45 - 16:30
Hall B
State of the Art: Educational:
Around the Time of Birth: Parent Mental Health
Chairperson:
Julian Neil Beezhold (United Kingdom)
 Around the Time of Birth: Parent Mental Health
Gisele Apter (France)
15:00 - 16:30
Hall C
European:
Challenges for European Psychiatry
Chairpersons:
Wolfgang Gaebel (Germany)
Peter Falkai (Germany)
 The EPA Action Plan: A Roadmap for European Psychiatry
Wolfgang Gaebel (Germany)
 From Psychiatry in Europe to European Psychiatry: The EPA Council of NPAs Role
P. Falkai (Germany)
 Example 1: Economic Crises and Mental Health Planning in Europe
Manuel Martin-Carrasco (Spain)
 Example 2: Defining a Common Framework for Post-Graduate Education in European Psychiatry
Rutger Jan Van der Gaag (Netherlands)
15:00 - 16:30
Hall M
Research:
Symposium: Parental psychopathology and children's developmental trajectories: data from prospective cohort studies
Chairpersons:
Anita Riecher-Rössler (Switzerland)
Maria Melchior (France)
 Family socioeconomic position as a moderator of the association between parental psychopathology and children's
outcomes: data from France
M. Melchior (France)
 Impact of maternal prenatal risk factors on oxytocin methylation, and on occurrence of conduct disorders during
adolescence
E.D. Barker, C.A.M. Charlotte (United Kingdom)
 The MATQUID cohort: links between maternal depressive symptoms and children's developmental trajectories
Sutter-Dallay (France)
 Maternal depression and children's growth: data from Brazil.
P. Surkan (USA)
29 | P a g e
15:00 - 16:30
Hall N1
Research:
Symposium: The influence of socio-cultural factors on mental health of immigrants
Chairpersons:
Meryam Schouler-Ocak (Germany)
Iris Tatjana Graef-Calliess (Germany)
 When local poverty is more important than your income: Migrant mental health in inner cities
Michael Rapp (Germany)
 Biological effects of social exclusion
Heinz, U. Kluge, M. Schouler-Ocak, M. Rapp (Germany)
 The role of stigma and discrimination on mental health of immigrants
Marianne Kastrup (Denmark)
 Therapeutic interventions for immigrants with a mental illness
D. Bhugra (United Kingdom)
15:00 - 16:30
Hall N2
Educational:
Academia Educational Course:
Cognitive-behavioural treatment in obsessive-compulsive disorder
Fritz Hohagen (Germany)
15:00 - 16:30
Hall N3
Educational:
Academia Educational Course: Part 2:1
Writing, publishing and reviewing a clinical scientific paper
Christoph Lauber (Switzerland)
Povl Munk-Jørgensen (Denmark)
15:00 - 16:30
Hall L1
Clinical:
Symposium: Nature and narratives of depression
Chairpersons:
Michael Musalek (Austria)
Maria Luisa Figueira (Portugal)
 Sadness and Depression: what is the psychopathologic border?
F. Oyebode (United Kingdom)
 Distimia, Unipolar and Bipolar Depression: are modern nosology making us crazy?
L. Madeira (Portugal)
 Causal connection between Depression and Paranoia
R.K.R. Salokangas, J. Hietala, M. Heinimaa, T. From, H. Graf von Reventlow, D. Linszen, P. Dingemans, M. Birchwood, P.
Patterson, F. Schultze-Lutter, J. Klosterkötter, S. Ruhrmann (Finland)
 Addictions and Depression: the paradise lost
Gilberto DiPetta (Italy)
15:00 - 16:30
Hall L8
Free Communications / e-Poster Oral 18
15:00 - 16:30
Hall L4
Free Communications / e-Poster Oral 19
30 | P a g e
15:00 - 16:30
ECP Hall M3
European Track:
EFPT/ ECPC-EPA Symposium: All Psychiatrists are Equal; but are Some More than Others?
Chairpersons:
Andrew Brittlebank (United Kingdom)
Daria Smirnova (Russia)
 Similarities and Differences in Training across Europe
Marisa Casanova Dias (United Kingdom)
 Teo-pc Pilot Study - Trainees' Experiences and Opinions Regarding the Uems Psychiatric Competencies in their National
Training Programmes
Ana Giurgiuca (Romania)
 What Patients Want from Psychiatrists
Paul Arteel (Belgium)
 The Image of Psychiatrists
Livia De Picker (Belgium)
17:00 - 18:30
Hall B
Educational:
Symposium: Concepts of mental disorders - time to change?
Chairpersons:
Wolfgang Gaebel (Germany)
Dinesh Bhugra (United Kingdom)
 Developing ICD-11 - current state of the art
Geoffrey M. Reed (Switzerland)
 ICD-11 and DSM-5 - similarities and differences
W. Gaebel (Germany)
 Culturally sensitive classification of mental disorders
D. Bhugra (United Kingdom)
 Identifying brain mechanisms as defining elements of mental disorders
Philip McGuire (United Kingdom)
 Discussant
Bruce Cuthbert (USA)
17:00 - 18:30
Hall C
Research:
Symposium: Genetics and functional imaging underlying major depressive and anxiety disorders
Chairpersons:
Thomas Frodl (Germany)
Andrew McIntosh (United Kingdom)
 Genetics and neurobiology of anxiety and depression
A.M. McIntosh, H.C. Whalley, S.M. Lawrie (United Kingdom)
 Functional, molecular and translational imaging in anxiety and depression
Rupert Lanzenberger (Austria)
 Functional underpinnings of emotional processing
Phillippe Fossati (France)
 Integrated functional Imaging and genetics in depression and anxiety
T. Frodl, M. Szyf, A. Carballedo, M. Gill, L. Booij (Germany)
31 | P a g e
17:00 - 18:30
Hall M
Research:
Symposium: Mobile technologies in psychiatry
Chairpersons:
Joel Swendsen (France)
Marion Leboyer (France)
 Translational mobile psychiatry
Aroldo Dargél (Brazil)
 Advances in the Real-time Documentation of Psychosis and Suicidal Ideation
J. Palmier-Claus, P. Taylor, J. Ainsworth, S. Lewis (United Kingdom)
 Ecological Momentary Assessment: statistical issues
J.B. Nezlek (USA)
 Applications of Ecological Momentary Assessment in clinical practice
J. Swendsen (France)
17:00 - 18:30
Hall N1
Clinical:
Workshop: Translation of latest research findings into clinical suicide prevention
Chairpersons:
Marco Sarchiapone (Italy)
Dan Rujescu (Germany)
 Analysis of personality features in the assessment of suicide risk
Vladimir Carli (Sweden)
 Electrodermal hyporeactivity and suicide risk in depressed patients
M. Sarchiapone, L.H. Thorell, M. Iosue (Italy)
 From social exclusion to psychological pain
P. Courtet (France)
 Genetics of suicidal behavior and personality traits
Dan Rujescu (Germany)
17:00 - 18:30
Hall N2
Educational:
Academia Educational Course:
Cognitive-behavioural treatment in obsessive-compulsive disorder
Fritz Hohagen (Germany)
17:00 - 18:30
Hall N3
Educational:
Academia Educational Course: Writing, publishing and reviewing a clinical scientific paper: Part 2
Chairpersons:
Povl Munk-Jørgensen (Denmark)
Christoph Lauber (Switzerland)
32 | P a g e
17:00 - 18:30
Hall L1
Clinical:
Symposium: Challenges in diagnosis and treatment of behavioral addictions
Chairpersons:
Falk Kiefer (Germany)
Geert Dom (Belgium)
 Psychological and neurobiological mechanisms of pathological internet use
T. Lemenager (Germany)
 Imaging studies on cue-reactivity in pathological gambling
Heinz, N. Romanczuk-Seiferth (Germany)
 Internet based retraining as a treatment for gambling disorders
M. Boffo, W. Ronny, T. Pronk, R.W. Wiers, G. Dom (Belgium)
 The ‘ins and outs’ of sex differences in pathological gambling
R. Van den Bos (Netherlands)
17:00 - 18:30
Hall L8
European:
Symposium: Image of psychiatry in Europe: Where are we and where should we go?
Chairpersons:
Wolfgang Maier (Germany)
Pierre Vallon (Switzerland)
 Could we improve the image of psychiatry in Germany the last 20 years?
Matthias Angermeyer (Germany)
 Combating suicide successfully. Good news for psychiatry?
Danuta Wasserman (Sweden)
 Closing down the largest state mental in Hungary. Economic reasons or bad image of psychiatry?
Istvan Bitter (Hungary)
 What can psychiatry do to improve its image in Europe?
N. Sartorius (Switzerland)
17:00 - 18:30
Hall L4
Free Communications / e-Poster Oral 20
17:00 - 18:30
ECP Hall M3
Educational Track:
Training Workshop: What to do if you are stalked by a Patient?
Chairpersons:
Defne Eraslan (Turkey)
Olga Paravaya (Belarus) AFP
 To be advised
Julian Neil Beezhold (United Kingdom)
 To be advised
Silvana Galderisi (Italy)
33 | P a g e

Download Report